Injectable Drugs For Type-2 Diabetes Market - Top Companies and Manufacturers

Companies Dominating the Injectable Drugs for Type-2 Diabetes Landscape

AstraZeneca Plc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
GlaxoSmithKline Plc.
Merck & Co., Inc.
Boehringer Ingelheim Pharmaceuticals, Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Novo Nordisk A/S
Sanofi
Eli Lilly and Company

Browse Key Market Insights with Data Illustration:

Injectable Drugs for Type-2 Diabetes Market Size, Forecast Report 2037

In the News

May 6, 2020 - Pharmaceutical giant AstraZeneca’s diabetes drug Farxiga has become the first in its class to win U.S. approval as a treatment for heart failure, opening up a major new market opportunity outside of the medicine’s established field.
May 2020 - Danish drug maker Novo Nordisk stated that as per their research one of its marketed diabetes medication semaglutide, seems to work in another widespread disease, a liver condition known as NASH.

Frequently Asked Questions (FAQ)

Injectable Drugs for Type-2 Diabetes Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037.

North America industry is estimated to hold largest revenue share by 2037, backed by increasing prevalence of type 2 diabetes and obesity in the region.

The major players in the market are AstraZeneca Plc., GlaxoSmithKline Plc., Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novo Nordisk A/S, Sanofi, Eli Lilly and Company, and others.

Injectable Drugs For Type-2 Diabetes Market - Top Companies and Manufacturers

Companies Dominating the Injectable Drugs for Type-2 Diabetes Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the injectable drugs for Type-2 diabetes market?

What are the factors driving the injectable drugs for Type-2 diabetes landscape?

Which region dominated the majority of injectable drugs for Type-2 diabetes industry share?

Who are the key players in the injectable drugs for Type-2 diabetes sector?